AB0924 CALCIFIC TENDONITIS OF THE ROTATOR CUFF: PERIOSTIN ENRICHMENT IS ASSOCIATED WITH A BETTER RESPONSE TO ULTRASOUND-GUIDED PERCUTANEOUS LAVAGE
| العنوان: | AB0924 CALCIFIC TENDONITIS OF THE ROTATOR CUFF: PERIOSTIN ENRICHMENT IS ASSOCIATED WITH A BETTER RESPONSE TO ULTRASOUND-GUIDED PERCUTANEOUS LAVAGE |
|---|---|
| المؤلفون: | E. Correia, Frédéric Blanchard, Christelle Darrieutort-Laffite, B. Le Goff, Paul Arnolfo |
| المصدر: | Annals of the Rheumatic Diseases. 79:1762.1-1763 |
| بيانات النشر: | BMJ, 2020. |
| سنة النشر: | 2020 |
| مصطلحات موضوعية: | medicine.medical_specialty, biology, business.industry, Immunology, Calcific tendinitis, Tendonitis, Periostin, medicine.disease, Placebo, Gastroenterology, General Biochemistry, Genetics and Molecular Biology, Rheumatology, Osteoprotegerin, Methylprednisolone, Internal medicine, biology.protein, Immunology and Allergy, Medicine, Osteopontin, business, Calcification, medicine.drug |
| الوصف: | Background:Calcific tendonitis of the rotator cuff is a frequent cause of chronic shoulder pain. It is due to apatite deposits within the tendons. Little data are currently available about proteins associated to crystals within deposits.Objectives:The aim of the study was to quantify 6 proteins in calcific powders obtained from patients who have undergone an ultrasound-guided percutaneous lavage (UGPL) of their calcification and to look for correlations between their concentration and patient characteristics.Methods:Calcific powders were obtained from patients included in the CALCECHO trial whose main objective was to compare post-procedure pain between two groups: methylprednisolone or placebo injected at the end of the lavage [1]. Based on preliminary proteomic data and literature data, the following proteins have been selected and quantified by ELISA: Pigment-epithelium Derived Factor (PEDF), Osteopontin (OPN), Periostin (POSTN), Activin A (ACT A), Osteoprotegerin (OPG) and Bone Morphogenic Protein-2 (BMP-2). The level of each protein was expressed in µg per pg of the total proteins present in the sample. These proteins have been selected for their link to the mineralization. Correlations between the level of each protein and radiographic and ultrasound appearance of the calcific deposits were sought. We also looked for correlations between level of each protein and duration of pain or response to UGPL (Mann-Whitney test).Results:Sixty-six samples were studied: mean age was 48.9 (+/- 9.7) and 68% were female. Mean duration of shoulder pain was 30 months with a mean VAS pain of 68/100 (+/-14). Mean calcification size was 1.8 cm. Results of ELISA were as follows: mean level of PEDF at 1097 pg/µg, mean level of OPG at 135 pg/µg, mean level of POSTN at 6.9 pg/µg, mean level of ACT A at 19.6 pg/µg and mean level of OPN at 49.6 pg/µg although BMP-2 was undetectable. There was no correlation between level of proteins and the size of the calcification or the duration of pain. There was no difference in protein levels between type A and type B calcifications on radiography (classification of the French Society for Arthroscopy). In contrast, levels of POSTN and OPN were significantly higher in nodular calcifications compared to the homogenous (p=0.003 and p=0.01 respectively) or fragmented types (p=0.03 and p=0.04 respectively). Furthermore, calcifications without acoustic shadowing were enriched in POSTN compared to those with (p=0.04). Finally, the periostin level was significantly higher in calcifications that have responded well to UGPL (p=0.02).Conclusion:In this cohort of patients treated by UGPL, we observed higher levels of POSTN and OPN in the less dense calcifications and POSTN enrichment appeared to be associated with a better response to UGPL. Considering these data, further studies will be necessary to better understand the role of this protein in calcific tendonitis.References:[1]Darrieutort-Laffite C, Varin S, Coiffier G, Albert JD, Planche L, Maugars Y, Cormier G, Le Goff B. Are Corticosteroid Injections Needed After Needling and Lavage of Calcific Tendinitis: A Randomized, Double-Blind, Non-Inferiority Trial. Ann Rheum Dis. 2019 Jun;78(6):837-843.Disclosure of Interests:None declared |
| تدمد: | 1468-2060 0003-4967 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_________::dd3516f2fe03a39e21da6b7a4781b4d9Test https://doi.org/10.1136/annrheumdis-2020-eular.2632Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi...........dd3516f2fe03a39e21da6b7a4781b4d9 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 14682060 00034967 |
|---|